TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 60 filers reported holding TYRA BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,686,847 | -23.4% | 3,898,827 | -5.3% | 0.01% | -16.7% |
| Q2 2023 | $70,110,279 | -30.7% | 4,116,869 | -34.6% | 0.01% | +20.0% |
| Q1 2023 | $101,176,304 | +243.2% | 6,295,974 | +62.3% | 0.01% | +66.7% |
| Q4 2022 | $29,481,335 | -16.7% | 3,879,123 | -3.7% | 0.00% | -25.0% |
| Q3 2022 | $35,391,000 | +24.7% | 4,026,301 | +1.5% | 0.00% | +33.3% |
| Q2 2022 | $28,372,000 | -35.2% | 3,968,090 | -3.0% | 0.00% | 0.0% |
| Q1 2022 | $43,764,000 | -10.3% | 4,090,085 | +17.9% | 0.00% | -25.0% |
| Q4 2021 | $48,806,000 | +45.4% | 3,468,831 | +81.7% | 0.00% | +33.3% |
| Q3 2021 | $33,573,000 | – | 1,908,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $47,187,000 | 19.65% |
| Nextech Invest Ltd. | 2,518,582 | $26,949,000 | 7.69% |
| TCG Crossover Management, LLC | 896,418 | $9,592,000 | 3.85% |
| Boxer Capital, LLC | 6,448,359 | $68,997,000 | 3.55% |
| Fairmount Funds Management LLC | 1,284,990 | $13,749,000 | 3.25% |
| RA Capital Management | 7,236,454 | $77,430,000 | 1.69% |
| Frazier Life Sciences Management, L.P. | 1,327,665 | $14,206,000 | 1.21% |
| BVF INC/IL | 2,472,327 | $26,454,000 | 1.06% |
| Cormorant Asset Management, LP | 757,432 | $8,105,000 | 0.62% |
| Sio Capital Management, LLC | 111,033 | $1,188,000 | 0.39% |